133 related articles for article (PubMed ID: 26886640)
1. CD34 Over-Expression is Associated With Gliomas' Higher WHO Grade.
Kong X; Guan J; Ma W; Li Y; Xing B; Yang Y; Wang Y; Gao J; Wei J; Yao Y; Xu Z; Dou W; Lian W; Su C; Ren Z; Wang R
Medicine (Baltimore); 2016 Feb; 95(7):e2830. PubMed ID: 26886640
[TBL] [Abstract][Full Text] [Related]
2. CD105 Over-expression Is Associated with Higher WHO Grades for Gliomas.
Kong X; Wang Y; Liu S; Xing B; Yang Y; Li Y; Ren Z; Su C; Ma W; Wang R
Mol Neurobiol; 2016 Jul; 53(5):3503-3512. PubMed ID: 26884265
[TBL] [Abstract][Full Text] [Related]
3. Does Tenascin have Clinical Implications in Pathological Grade of Glioma Patients?: A Systematic Meta-Analysis.
Kong X; Ma W; Li Y; Wang Y; Guan J; Gao J; Wei J; Yao Y; Lian W; Xu Z; Dou W; Xing B; Ren Z; Su C; Yang Y; Wang R
Medicine (Baltimore); 2015 Aug; 94(32):e1330. PubMed ID: 26266377
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Implications of Chemokine Receptor CXCR4 in Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Lv S; Sun B; Zhong X; Dai C; Wang W; Ma X; Song H; Shi R; Wang R
Mol Neurobiol; 2015 Aug; 52(1):555-61. PubMed ID: 25213993
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Implications of Transforming Growth Factor Beta in Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Yang X; Lv S; Zhou X; Liu Y; Li D; Shi R; Kang H; Zhang J; Xu Z
Mol Neurobiol; 2015 Aug; 52(1):270-6. PubMed ID: 25148935
[TBL] [Abstract][Full Text] [Related]
6. Relationship between chemokine/chemokine receptor and glioma prognosis and outcomes: Systematic review and meta-analysis.
Yang S; Luo M; Yang S; Yuan M; Zeng H; Xia J; Wang N
Int Immunopharmacol; 2024 May; 133():112047. PubMed ID: 38631221
[TBL] [Abstract][Full Text] [Related]
7. The impact of survivin on prognosis and clinicopathology of glioma patients: a systematic meta-analysis.
Lv S; Dai C; Liu Y; Shi R; Tang Z; Han M; Bian R; Sun B; Wang R
Mol Neurobiol; 2015; 51(3):1462-7. PubMed ID: 25063470
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and Prognostic Significance of CD133 in Glioma Patients: A Meta-Analysis.
Han M; Guo L; Zhang Y; Huang B; Chen A; Chen W; Liu X; Sun S; Wang K; Liu A; Li X
Mol Neurobiol; 2016 Jan; 53(1):720-727. PubMed ID: 25589004
[TBL] [Abstract][Full Text] [Related]
9. Is CD147 a New Biomarker Reflecting Histological Malignancy of Gliomas?
Kong X; Wang Y; Dai C; Ma W; Wang R
Mol Neurobiol; 2017 Mar; 54(2):1568-1576. PubMed ID: 27206428
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Utility of Matrix Metalloproteinase 9 in Evaluating Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Yang X; Lv S; Liu Y; Li D; Shi R; Tang Z; Fan J; Xu Z
Mol Neurobiol; 2015 Aug; 52(1):38-44. PubMed ID: 25108671
[TBL] [Abstract][Full Text] [Related]
11. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
Wu B; Sun C; Feng F; Ge M; Xia L
J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
[TBL] [Abstract][Full Text] [Related]
12. Morphometric study of microvessels in primary CNS tumors and its correlation with tumor types and grade.
Deb P; Boruah D; Dutta V
Microvasc Res; 2012 Jul; 84(1):34-43. PubMed ID: 22465694
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic significance of COX-2 in glioma patients: a meta-analysis.
Wang J; Xiang C; Cai Y; Mei Z; Lu Q; Liu B; Zou L
Arq Neuropsiquiatr; 2022 Dec; 80(12):1254-1261. PubMed ID: 36580964
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of microRNA-155 expression in gliomas: A meta-analysis.
Zhou Y; Wang X; Liu Z; Huang X; Li X; Cheng K; Jiang X
Clin Neurol Neurosurg; 2019 Jan; 176():103-109. PubMed ID: 30554090
[TBL] [Abstract][Full Text] [Related]
15. Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.
Hu L; Lv QL; Chen SH; Sun B; Qu Q; Cheng L; Guo Y; Zhou HH; Fan L
Int J Environ Res Public Health; 2016 Apr; 13(4):433. PubMed ID: 27104549
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas.
Hou C; Ishi Y; Motegi H; Okamoto M; Ou Y; Chen J; Yamaguchi S
J Neurooncol; 2019 Nov; 145(2):201-210. PubMed ID: 31506754
[TBL] [Abstract][Full Text] [Related]
17. Dynamic Contrast-Enhanced Perfusion MRI and Diffusion-Weighted Imaging in Grading of Gliomas.
Arevalo-Perez J; Peck KK; Young RJ; Holodny AI; Karimi S; Lyo JK
J Neuroimaging; 2015; 25(5):792-8. PubMed ID: 25867683
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic value of the WEE1 kinase in gliomas.
Music D; Dahlrot RH; Hermansen SK; Hjelmborg J; de Stricker K; Hansen S; Kristensen BW
J Neurooncol; 2016 Apr; 127(2):381-9. PubMed ID: 26738845
[TBL] [Abstract][Full Text] [Related]
19. Pediatric high-grade glioma: current molecular landscape and therapeutic approaches.
Braunstein S; Raleigh D; Bindra R; Mueller S; Haas-Kogan D
J Neurooncol; 2017 Sep; 134(3):541-549. PubMed ID: 28357536
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the extent of resection and the survival of patients with low-grade gliomas: a systematic review and meta-analysis.
Xia L; Fang C; Chen G; Sun C
BMC Cancer; 2018 Jan; 18(1):48. PubMed ID: 29306321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
